BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17896769)

  • 1. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro.
    Xie J; Tan RS; Wang CH
    J Biomed Mater Res A; 2008 Jun; 85(4):897-908. PubMed ID: 17896769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro.
    Xie J; Marijnissen JC; Wang CH
    Biomaterials; 2006 Jun; 27(17):3321-32. PubMed ID: 16490248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in long-term protein delivery using biodegradable microparticles.
    Ye M; Kim S; Park K
    J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
    Pinto E; Zhang B; Song S; Bodor N; Buchwald P; Hochhaus G
    Pharmazie; 2010 Jun; 65(6):429-35. PubMed ID: 20614691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
    Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
    Int J Pharm; 2012 May; 427(2):299-304. PubMed ID: 22366485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cisplatin cytotoxicity delivered from PLGA-systems.
    Moreno D; de Ilarduya CT; Bandrés E; Buñuales M; Azcona M; García-Foncillas J; Garrido MJ
    Eur J Pharm Biopharm; 2008 Mar; 68(3):503-12. PubMed ID: 17881198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
    Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
    Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R; Shi Ng L; Wang CH
    Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
    Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
    Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable cisplatin microspheres for direct brain injection: preparation and characterization.
    García-Contreras L; Abu-Izza K; Lu DR
    Pharm Dev Technol; 1997 Feb; 2(1):53-65. PubMed ID: 9552431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.
    Xie J; Wang CH
    Pharm Res; 2006 Aug; 23(8):1817-26. PubMed ID: 16841195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin.
    Moreno D; Zalba S; Colom H; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
    Eur J Pharm Sci; 2009 Jun; 37(3-4):341-50. PubMed ID: 19491025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles.
    Horie RT; Sakamoto T; Nakagawa T; Tabata Y; Okamura N; Tomiyama N; Tachibana M; Ito J
    Laryngoscope; 2010 Feb; 120(2):377-83. PubMed ID: 19950377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
    He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of protein drugs in biodegradable microparticles by co-axial electrospray.
    Xie J; Ng WJ; Lee LY; Wang CH
    J Colloid Interface Sci; 2008 Jan; 317(2):469-76. PubMed ID: 17945246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel composite microparticles for protein stabilization and delivery.
    Schoubben A; Blasi P; Giovagnoli S; Perioli L; Rossi C; Ricci M
    Eur J Pharm Sci; 2009 Feb; 36(2-3):226-34. PubMed ID: 18950709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode.
    Xie J; Wang CH
    Biotechnol Bioeng; 2007 Aug; 97(5):1278-90. PubMed ID: 17216662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the size of biodegradable microparticles on drug release: experiment and theory.
    Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP
    J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.